期刊
BIOMARKERS IN MEDICINE
卷 16, 期 14, 页码 1055-1066出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2022-0287
关键词
CA125; epithelial ovarian cancer; FIGO; HE4; recurrence; ROMA index
资金
- Ningxia Key Research and Development Program [2019BFG02002]
This study assessed the predictive and diagnostic value of the ROMA index for EOC recurrence. The results showed that the ROMA index was strongly associated with clinical characteristics and had a significant association with recurrence-free survival above the cutoff value. The ROMA index had a higher sensitivity than CA125 and HE4 for recurrence diagnosis.
Aim: This study aimed to assess the predictive and diagnostic value of the risk of ovarian malignancy algorithm (ROMA) index for epithelial ovarian cancer (EOC) recurrence. Materials & methods: The clinical features and follow-up data of 159 EOC cases were studied. The ROMA index was calculated by serum CA125 and HE4 levels with menopausal status. Recurrence-free survival was evaluated for an end point. Results: The ROMA was strongly associated with clinical characteristics. The ROMA index above the cutoff value (34.71%) was significantly associated with recurrence-free survival. The ROMA index had a significantly higher sensitivity (90.59%) than CA125 (84.71%) and HE4 (80.80%) for recurrence diagnosis, and its optimal cutoff value was 17.07%. Conclusion: The primary ROMA index is a predictive factor in EOC recurrence and has better performance in the diagnosis of EOC recurrence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据